跳至主要内容
临床试验/NL-OMON46616
NL-OMON46616已完成2 期

The influence of a Pulsating Electrostatic Field (PESF) on oxygen saturation, quality of life and exercise capacity of COPD patients, a single center, double blind, placebo controlled study. - Influence of PESF on oxygen saturation, QoL and exercise capacity in COPD

Heerenveen Ziekenhuis, De Tjongerschans0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 40-85 years old
  • - Male and female
  • - COPD patients, post-bronchodilator FEV1/FVC <70%, and FEV1 < 50%predicted oxygen saturation without suppletion * 90% (home use of oxygen suppletion is allowed, but will be stopped during PESF-treatment)
  • - Stable medication (no foreseeable need to change therapy)
  • - Able to understand the purpose and method of research after adequate information and to ability to decide on participation
  • - Signed form of consent

排除标准

  • - Known malignant condition with limited life expactancy
  • - Carrier of electrical equipment (pacemaker, ICD etc.)
  • - COPD exacerbation in the last 3 weeks
  • - Participation in other research
  • - Woman who are pregnant, breastfeeding or of childbearing age without effective contraception unless they meet the postmenopausal definition: 12 months of natural omenorrhea or 6 months of spontaneous ammenorrhea with serum FSH>40 mIU/mL or the use of one or more of the following acceptable methods of birth control: a) surgical sterilication, b) hormonal contraception, c) barrier methods: condom or occlusion cap with spermicide, d) constant abstention.
  • - Manifest acute inflammation
  • - Patients with manifest decompensatio cordis
  • - Rehabilitation/reactivation programs within 2 months before or during the study

研究者

发起方
Heerenveen Ziekenhuis, De Tjongerschans

相似试验